Page last updated: 2024-08-05 11:56:39

dipeptide zwitterion

Any peptide zwitterion comprising two amino acid residues. Major structure at pH 7.3.

ChEBI ID: 90799

Members (22)

MemberDefinitionRole
alanylalanineA dipeptide zwitterion resulting from the transfer of a proton from the carboxy to the amino group of Ala-Ala; major species at pH 7.3.Ala-Ala zwitterion; L-alanyl-L-alanine
alanylglutamineA peptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of Ala-Gln.Ala-Gln zwitterion; Ala-Gln
alanylglycineA peptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of Ala-Gly.Ala-Gly zwitterion; Ala-Gly
alanylprolineA peptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of Ala-Pro.Ala-Pro zwitterion; Ala-Pro
aspartameA dipeptide zwitterion resulting from transfer of a proton from the carboxy to the amino group of aspartame; major species at pH 7.3.aspartame zwitterion; aspartame
cysteinylglycineThe zwitterion of L-cysteinylglycine resulting from the transfer of a proton from the hydroxy group of glycine to the amino group of cysteine. Major microspecies at pH 7.3.L-cysteinylglycine zwitterion; L-cysteinylglycine
glutaurineA dipeptide zwitterion that is glutaurine in which a proton has been transferred from the carboxy group to the alpha-amino group.glutaurine zwitterion; glutaurine
glycyl-l-phenylalanineA peptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of Gly-Phe.Gly-Phe zwitterion; Gly-Phe
glycylglutamineA peptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of Gly-Gln.Gly-Gln zwitterion; Gly-Gln
glycylglycineThe zwitterion from the dipeptide glycylglycine formed by proton transfer from the OH of the carboxy group to the terminal amino group.glycylglycine zwitterion; glycylglycine
glycylhistidineA dipeptide zwitterion resulting from transfer of a proton from the carboxy to the amino group of glycyl-L-histidine; major species at pH 7.3.Gly-His zwitterion; Gly-His
glycylleucineA dipeptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of Gly-Leu. Major species at pH 7.3.Gly-Leu; glycyl-L-leucine zwitterion
glycylprolineA peptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of Gly-Pro.Gly-Pro zwitterion; Gly-Pro
glycylsarcosineA dipeptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of glycylsarcosine. Major microspecies at pH 7.3.glycylsarcosine zwitterion; glycylsarcosine
histidinoalanineA dipeptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of His-Ala. Major species at pH 7.3.His-Ala zwitterion; His-Ala
histidylleucineA dipeptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of His-Leu. Major species at pH 7.3.His-Leu zwitterion; His-Leu
histidylprolineA dipeptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of His-Pro. Major species at pH 7.3.His-Pro zwitterion; His-Pro
homocarnosineA zwitterion arising from transfer of a proton from the carboxy to the amino group of L-homocarnosine; major species at pH 7.3.L-homocarnosine zwitterion; L-homocarnosine
leucylprolineA peptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of Leu-Pro.Leu-Pro zwitterion; Leu-Pro
phenylalanylalanineA peptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of Phe-Ala; major species at pH 7.3.Phe-Ala zwitterion; Phe-Ala
phenylalanylleucineA dipeptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of Phe-Leu.Phe-Leu zwitterion; Phe-Leu
prolylglycineThe zwitterion of L-prolinylglycine resulting from the transfer of a proton from the hydroxy group of glycine to the amino group of proline. Major microspecies at pH 7.3.L-prolinylglycine zwitterion; L-prolylglycine

Research

Studies (2,658)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-1990589 (22.16)18.7374
1990's569 (21.41)18.2507
2000's661 (24.87)29.6817
2010's631 (23.74)24.3611
2020's208 (7.83)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials226 (7.52%)5.53%
Reviews152 (5.06%)6.00%
Case Studies42 (1.40%)4.05%
Observational1 (0.03%)0.25%
Other2,583 (85.99%)84.16%